Emerging genetics of Lung Cancer & COPD

Emerging genetics of Lung Cancer & COPD Photo

Mutational analysis and genomics profiling in recent years have advanced the field of lung cancer genetics significantly. It is becoming more accepted now that the identification of genomic alterations in lung cancer can impact therapeutics, especially when the alterations represent “oncogenic drivers” in the processes of tumorigenesis. Genetic testing is now a routine part of diagnosis and staging for every patient suffering with lung cancer and COPD. Genetics plays an important role as less than 20% of smokers develop this deadly disease in their lifetime and non-smokers with a family history of cancer have an increased risk of lung cancer.

Are you interested in

Mail us at

Program Inquiry
General Enquiry
Sponsorship Opportunity
More details about sponsorship:sponsors@alliedacademies.com

Authorization Policy

By registering for the conference you grant permission to Allied Academies to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.
Copyright © 2019-2020 Allied Academies, All Rights Reserved.